Professor | Wu Yan | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Wu Yan
Contact Information	wuyan32@mail.sysu.edu.cn
Language ability	Chinese, English
Province	Guangdong

Upload Avatar (500 x 500)

Name

Wu Yan

Contact Information

wuyan32@mail.sysu.edu.cn

Language ability

Chinese, English

Province

Guangdong

University/Lab Affiliation and Title	Sun Yat-Sen University
Faculty	Life Sciences
Academic Background & Achievements	2002-09 to 2006-06: Bachelor of Science, Sun Yat-sen University 2006-09 to 2011-06: Doctor of Science, Sun Yat-sen University Achievement: Revealed new mechanisms of tumor immune escape and identified potential immunotherapy targets
Work Experience	2011-08 to 2013-08: Postdoctoral Fellow, Sun Yat-sen University 2013-08 to 2014-01: Lecturer, Sun Yat-sen University 2014-01 to 2023-06: Associate Professor, Sun Yat-sen University 2023-06 to present: Professor, Sun Yat-sen University
Awards	2019: Selected for Guangdong Province Special Support Plan for Young Top Talents 2014: National Natural Science Second Prize as the fourth contributor

University/Lab Affiliation and Title

Sun Yat-Sen University

Faculty

Life Sciences

Academic Background & Achievements

2002-09 to 2006-06: Bachelor of Science, Sun Yat-sen University
2006-09 to 2011-06: Doctor of Science, Sun Yat-sen University
Achievement: Revealed new mechanisms of tumor immune escape and identified potential immunotherapy targets

Work Experience

2011-08 to 2013-08: Postdoctoral Fellow, Sun Yat-sen University
2013-08 to 2014-01: Lecturer, Sun Yat-sen University
2014-01 to 2023-06: Associate Professor, Sun Yat-sen University
2023-06 to present: Professor, Sun Yat-sen University

Awards

2019: Selected for Guangdong Province Special Support Plan for Young Top Talents
2014: National Natural Science Second Prize as the fourth contributor

Areas of Focus	Tumor Immunology
Publications	Downregulation of phosphoserine phosphatase potentiates tumor immune environments to enhance immune checkpoint blockade therapy., Peng ZP, Liu XC, Ruan YH, Jiang D, Huang AQ, Ning WR, Jiang ZZ, Zheng L, Wu Y., 2023 Neutrophil extracellular traps induce tumor metastasis through dual effects on cancer and endothelial cells., Jiang ZZ, Peng ZP, Liu XC, Guo HF, Zhou MM, Jiang D, Ning WR, Huang YF, Zheng L, Wu Y., 2022 Carbonic anhydrase XII mediates the survival and pro-metastatic functions of macrophages in human hepatocellular carcinoma., Ning WR, Jiang D, Liu XC, Huang YF, Peng ZP, Jiang ZZ, Kang T, Zhuang SM, Wu Y, Zheng L., 2022 Type I IFNs repolarized a CD169+ macrophage population with anti-tumor potentials in hepatocellular carcinoma., Liao J, Zeng DN, Li JZ, Hua QM, Huang CX, Xu J, Wu C, Zheng L, Wen WP, Wu Y., 2022 Glycolytic activation of monocytes regulates the accumulation and function of neutrophils in human hepatocellular carcinoma., Peng ZP, Jiang ZZ, Guo HF, Zhou MM, Huang YF, Ning WR, Huang JH, Zheng L, Wu Y., 2020 Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma., Liao J, Zeng DN, Li JZ, Hua QM, Xiao Z, He C, Mao K, Zhu LY, Chu Y, Wen W, Zheng L, Wu Y., 2020 Glycolytic activation of peritumoral monocytes fosters immune privilege via PFKFB3-PD-L1 axis in human hepatocellular carcinoma., Chen DP, Ning WR, Jiang ZZ, Peng ZP, Zhu LY, Zhuang SM, Kuang DM, Zheng L, Wu Y., 2019 Peritumoral monocytes induce cancer cell autophagy to facilitate the progression of human hepatocellular carcinoma., Chen DP, Ning WR, Li XF, Wei Y, Lao XM, Wang JC, Wu Y, Zheng L., 2018

Areas of Focus

Tumor Immunology

Publications

Downregulation of phosphoserine phosphatase potentiates tumor immune environments to enhance immune checkpoint blockade therapy., Peng ZP, Liu XC, Ruan YH, Jiang D, Huang AQ, Ning WR, Jiang ZZ, Zheng L, Wu Y., 2023
Neutrophil extracellular traps induce tumor metastasis through dual effects on cancer and endothelial cells., Jiang ZZ, Peng ZP, Liu XC, Guo HF, Zhou MM, Jiang D, Ning WR, Huang YF, Zheng L, Wu Y., 2022
Carbonic anhydrase XII mediates the survival and pro-metastatic functions of macrophages in human hepatocellular carcinoma., Ning WR, Jiang D, Liu XC, Huang YF, Peng ZP, Jiang ZZ, Kang T, Zhuang SM, Wu Y, Zheng L., 2022
Type I IFNs repolarized a CD169+ macrophage population with anti-tumor potentials in hepatocellular carcinoma., Liao J, Zeng DN, Li JZ, Hua QM, Huang CX, Xu J, Wu C, Zheng L, Wen WP, Wu Y., 2022
Glycolytic activation of monocytes regulates the accumulation and function of neutrophils in human hepatocellular carcinoma., Peng ZP, Jiang ZZ, Guo HF, Zhou MM, Huang YF, Ning WR, Huang JH, Zheng L, Wu Y., 2020
Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma., Liao J, Zeng DN, Li JZ, Hua QM, Xiao Z, He C, Mao K, Zhu LY, Chu Y, Wen W, Zheng L, Wu Y., 2020
Glycolytic activation of peritumoral monocytes fosters immune privilege via PFKFB3-PD-L1 axis in human hepatocellular carcinoma., Chen DP, Ning WR, Jiang ZZ, Peng ZP, Zhu LY, Zhuang SM, Kuang DM, Zheng L, Wu Y., 2019
Peritumoral monocytes induce cancer cell autophagy to facilitate the progression of human hepatocellular carcinoma., Chen DP, Ning WR, Li XF, Wei Y, Lao XM, Wang JC, Wu Y, Zheng L., 2018

Tumor Immunology Macrophages Metabolism Reprogramming Hepatocellular Carcinoma Immune Escape Microenvironment Therapy Targets

Chunyu Wang - China Medical University

Jing Hu - Peking University

Yanping Xu - Tongji University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us